White Paper: Ethical Considerations of Imminent Death Donation

Slides:



Advertisements
Similar presentations
The Donor Most organ donors are accident victims that have suffered severe and eventually fatal injuries-often a severe head injury. Death is pronounced.
Advertisements

Midlands Collaborative, November 2012 Timely Identification and Referral of Potential Organ Donors Paul Murphy National Clinical Lead for Organ Donation.
LEGAL ISSUES IN AUTHORIZATION FOR ORGAN DONATION IN MISSOURI & KANSAS Laurence R. Tucker November 18, 2011.
Alexandra K. Glazier, JD, MPH DCD Ethics Next Speaker: Sponsored by.
Alexandra K. Glazier, JD, MPH Why Gift Law Matters: The Law and Ethics of Donor Designation Next Speaker: Sponsored by.
Organ Donation Past, Present and Future Donor Identification and Referral Louise Davey, Team Manager Dr Alex Manara, RCLOD South West 26 th June
ETHICAL ISSUES IN ORGAN DONATION Kate Payne, JD, RN Director, Ethics & Palliative Care Saint Thomas Hospital, Nashville, Tennessee Ascension Health.
Donation Process: Preparing for the Gift Breakout Session A Presenters: Jennifer Do, RN, Unit Director, Surgical Transplant ICU, Ronald Reagan UCLA Medical.
Donation After Cardiac Death May 26, 2010 Margie Whittaker, RN MSN.
Ad Hoc Disease Transmission Advisory Committee Spring 2015.
Living Donor Committee Update Christie Thomas, MB, FRCP, FASN, FAHA Medical Director, Kidney Transplant Program University of Iowa Hospitals Chair, OPTN/UNOS.
Challenges to Research and Innovation to Optimize Deceased Donor Organ Quality and Quantity Peter Abt, MD Sandy Feng, MD PhD American Society of Transplant.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Organ Donation Past, Present and Future Donor Identification and Referral Rachel Stoddard-Murden Dr Alex Manara 9 th July SOUTH WEST.
Organ Donation Past, Present and Future Donor Identification and Referral Jeremy Brown Huw Twamley 4 th June LONDON.
Proposal To Modify Existing or Establish New Requirements for the Psychosocial and Medical Evaluation of all Living Donors Living Donor Committee Spring.
Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Spring 2015.
UAGA Calif. Health & Safety CMS Collaborative Joint Commission 400.
OPTN OPTN/UNOS Ethics Committee Spring 2012 Regional Meeting Update Chair, Alexandra Glazier, MPH, JD Vice-Chair, Peter Reese, MD.
Proposal to Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Through Solid Organ Transplantation Ad Hoc Disease.
Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Fall 2014.
Ante mortem interventions in DCD Dr Malcolm Watters Regional Clinical Lead for Organ Donation 1.
Proposal to Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Through Solid Organ Transplantation Ad Hoc Disease.
David A. Gerber, MD Professor and Chief Division of Abdominal Transplantation Department of Surgery University of North Carolina at Chapel Hill.
Neurologically-Aware Donors: Donation After Circulatory Death Noël Stout, LPN, CTBS Myrna Garcia, BA Family Support Coordinators.
1 Proposal to Establish and Clarify Policy Requirements for Therapeutic Organ Donation Living Donor Committee Fall 2015.
Donation After Cardiac Death Margie Whittaker RN, MSN, CCRN, CNRN April 12, 2010.
1 Infectious Disease Verification to Enhance Patient Safety Operations and Safety Committee.
Donation After Cardiac Death
Guidance for VCA Deceased Donor Authorization (Resolution 7)
Case Study 24 y/o overdose with history of IVDA, found with needle in arm, & pronounced within 24 Hours of admission. Sharing Our Current Practices Hospital:
Improving Allocation of En Bloc Kidneys Public Comment Proposal
A White Paper Addressing Financial Incentives for Organ Donation
Thoracic Organ Transplantation Committee
Manipulation of the Waitlist Priority of the Organ Allocation System through the Escalation of Medical Therapies Ethics Committee.
Expedited Organ Placement Concept Paper
Guidance on Optimizing VCA Recovery from Deceased Donors
Clarify Informed Consent of Transmittable Conditions
Thoracic Organ Transplantation Committee
Thoracic Organ Transplantation Committee
One Legacy Organ Donation
National Webinar to Review Non-Discussion Agenda
Organ Procurement Organization Committee Report
Improving Dual Kidney Allocation
Thoracic Organ Transplantation Committee Spring 2015
Minority Affairs Committee Update
Eliminate the Use of Regions in VCA Distribution
Expedited Placement of Livers
Living Donor Committee
OPTN/UNOS Ethics Committee
VA Life-Sustaining Treatment Decisions Initiative
Living Donor Committee Spring 2014
Patient Affairs Committee
Guidance on Effective Practices in Broader Distribution
Membership & Professional Standards Committee Spring 2014
Operations and Safety Committee
Living Organ Donation by Persons with Certain Fatal Diseases who Meet the Criteria to be Living Organ Donors Ethics Committee.
Living Donor Committee Spring 2014
Minority Affairs Committee Update
OPTN/UNOS Living Donor Committee
Informed Consent for Kidney Paired Donation
Clarify Informed Consent of Transmittable Conditions
Living Donor Committee
Living Donor Committee
Living Donor Committee
Operations and Safety Committee Spring 2014
Operations and Safety Committee Spring 2014
Pediatric Transplantation Committee
White Paper: Ethics of Deceased Donor Organ Recovery without Requirement for Explicit Consent or Authorization Ethics Committee.
White Paper: Split Versus Whole Liver Transplantation
Presentation transcript:

White Paper: Ethical Considerations of Imminent Death Donation Ethics Committee

What is this resource? New white paper from the Ethics Committee Provides an ethical analysis of imminent death donation (IDD) Target audience: Transplant hospitals or OPOs counseling families or surrogates of potential donors Specifically those who want an option for donation when the potential donor does not meet brain death criteria and is not a DCD candidate In 2014, the a inter-committee workgroup lead by the Ethics Committee began an ethical analysis of imminent death donation. The work group included members of the OPO, Living Donor and Operations and Safety Committee. The Committee developed the white paper for IDD to provide guidance to transplant hospitals or OPOs that may be counseling families or surrogates of potential donors, particularly those families/surrogates who want an option for donation when the potential donor does not meet brain death criteria and the potential donor is not a candidate for DCD.

What is Imminent Death Donation (IDD)? IDD is a term that has been used for organ recovery from a live donor before withdrawal of ventilator support expected to result in the patient’s death. IDD applies to at least 2 types of potential donors: An individual with devastating neurologic injury that is considered irreversible and who is not brain dead. A patient who has capacity for medical-decision making, is dependent on life-support, has decided not to accept further life support who wants to donate IDD is a term that has been used for the recovery of a living donor organ immediately prior to an impending and planned withdrawal of ventilator support expected to result in the patient’s death. IDD applies two at least two types of potential donors. IDD might be applicable to an individual with devastating neurologic injury that is considered irreversible and who is not brain dead. Under this scenario, a surrogate would need to provide consent for living donation. IDD might also be applied to a patient who has capacity for medical-decision making, is dependent on life-support, has decided not to accept further life support and indicates the desire to donate organs prior to foregoing life support and death. This type of potential donor could provided informed consent, and would not be prohibited under current policy.

Background and Results of Ethical Analysis The Committee analyzed if IDD, compared to existing practices of attempting donation after cardiac death (DCD) could: Honor the preferences of the potential Support the preferences of the potential donor’s family or surrogate Increase the number of potential organ donors Increase the quality of organs donated for transplantation The work group’s motivations were to analyze whether, compared to existing practices of attempting donation after cardiac death (DCD), the IDD could:   honor the preferences of the potential donor (if known, concerning organ donation or the potential donor’s end-of-life care); support the preferences of the potential donor’s family or surrogate; increase the number of potential organ donors increase the quality of organs donated for transplantation

Background and Results of Ethical Analysis The Committee determined: IDD may be ethically appropriate and justified by the potential benefits to donors, donor families and recipients Lack of data makes it impossible to conclude if IDD would increase the number of organs available for transplant IDD has the potential to erode public trust in organ donation The work group concluded that there could be circumstances where LD-PPW may be ethically appropriate and justified by the potential benefits to donors, donor families and recipients The work group ultimately determined that at this time the lack of data makes it impossible to conclude whether the net number of transplants might decline or increase if LD-PPW were widely adopted. The work group recognized that the controversy regarding IDD has the potential to erode public trust in donation in general. There could be a misperception that families will be under undue pressure to donate organs prior to the patient’s death and withdraw ventilator support in circumstances where a patient would otherwise recover.

Final Recommendations The OPTN should not pursue IDD (at this time) due to its potential risks, the lack of community support and substantial challenges to implementation. In the future, it may be possible to adequately address those challenges through additional research, careful policy development or revision. Consequently, the Ethics Committee is recommending that that the OPTN discontinue work on IDD at this time, due to its potential risks, the lack of community support and substantial challenges to implementation. In the future, it may be possible to adequately address those challenges through additional research, careful policy development or revision.

How will members access this resource? Members will be able to access this resource through the OPTN website Current white papers are available under the Resources tab, select Ethics

Questions? Peter Reese, M.D. Committee Chair peter.reese@uphs.upenn.edu Lee Bolton Committee Liaison lee.bolton@unos.org